Disease-modifying therapies

Despite significant advancements in insulin therapy and glucose monitoring, managing type 1 diabetes remains challenging, and therapeutic options are limited. There is an urgent need for disease-modifying therapies that target the autoimmune root of the disease to prevent, delay, or modify its disease course. Such strategies have the potential to significantly improve both quality of life and long-term health outcomes for individuals living with type 1 diabetes.